Ignite Creation Date:
2024-05-05 @ 11:44 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00113048
Status:
TERMINATED
Last Update Posted:
2014-02-05
First Post:
2005-06-03
Brief Title:
Subcutaneously Administered CAMPATH in CD52 Expressing Hematologic Malignancies
Sponsor:
Genzyme a Sanofi Company
Organization:
Sanofi
Organization Data
Organization:
Sanofi
Class:
INDUSTRY
Study ID:
CAM111
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Genzyme a Sanofi Company
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Medical Monitor
Old Organization:
Genzyme Corporation